Tech Support


This line is for technical support.
For General Enquiries please click General Contact

SYMPOSIUM: Advanced Strategies for Translational Oncology Research

San Diego, October 3, 2019 - Hilton Torrey Pines

Hilton Torrey PinesThis year our annual San Diego symposium focuses on advanced strategies to progress translational oncology research and preclinical drug development.

Cancer research continues to be revolutionized by novel development and treatment approaches across oncology and immuno-oncology. As widespread innovation and advanced strategies continue to enhance preclinical models and technologies, the next generation of anticancer agents can continue to bring improved patient benefits.

The symposium will bring together oncology and immuno-oncology R&D and preclinical teams from pharmaceutical and biotech companies to facilitate cross discipline discussions on current techniques, and how to move forward with future approaches.

Discussion Topics Include:

  • New technologies for treating hematological malignancies
  • Novel targets for next generation oncology and immuno-oncology agents
  • The future of immunocompetent and humanized models for immunotherapy assessment

Presentation & Speakers

Francis Burrows, PhD

Vice President of Translational Research, Kura Oncology
KO-539 - A First-in-Class Menin-MLL Inhibitor for AML

Michael J. Newman, PhD

President and CEO, Decoy Biosystems
A Multiple Toll-Like Receptor (TLR) Agonist for Anti-Cancer and Anti-Viral Immunotherapy

Ingrid Joseph, DVM, PhD

Vice President, Pharmacology and Toxicology, Synthorx
THOR-707, A Novel Not-Alpha IL-2, Shows Efficacy as Single Agent and in Combination with Anti-PD-1 in Syngeneic Mouse Models and Elicits Durable Pharmacodynamic Responses in NHPs

Ana Paula (Galvao da Silva) Cugnetti, PhD

Principal Scientist, BioAtla

Sylvia F Boj, PhD

Scientific Director, Hubrecht Organoid Technology

Dean Campbell, PhD

Director, Scientific Engagement, Oncology, Crown Bioscience
MuPrime™, a Mouse Tumor Homograft Model Platform for Immuno-Oncology (I/O) Drug Discovery

Attendance is free, but seats are limited, reserve your space by submitting the registration form today!

Reserve Your Seat Now!

Reserve Your Seat

Your privacy is important to us.
We'll never share your information.